204 related articles for article (PubMed ID: 14757828)
1. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.
Terrillon S; Barberis C; Bouvier M
Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1548-53. PubMed ID: 14757828
[TBL] [Abstract][Full Text] [Related]
2. Arrestin effects on internalization of vasopressin receptors.
Bowen-Pidgeon D; Innamorati G; Sadeghi HM; Birnbaumer M
Mol Pharmacol; 2001 Jun; 59(6):1395-401. PubMed ID: 11353798
[TBL] [Abstract][Full Text] [Related]
3. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.
Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG
J Biol Chem; 1999 Nov; 274(45):32248-57. PubMed ID: 10542263
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of beta-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization.
Simaan M; Bédard-Goulet S; Fessart D; Gratton JP; Laporte SA
Cell Signal; 2005 Sep; 17(9):1074-83. PubMed ID: 15993749
[TBL] [Abstract][Full Text] [Related]
5. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.
Charest PG; Oligny-Longpré G; Bonin H; Azzi M; Bouvier M
Cell Signal; 2007 Jan; 19(1):32-41. PubMed ID: 16857342
[TBL] [Abstract][Full Text] [Related]
6. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2003 Apr; 278(16):14498-506. PubMed ID: 12574160
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.
Roosterman D; Cottrell GS; Padilla BE; Muller L; Eckman CB; Bunnett NW; Steinhoff M
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11838-43. PubMed ID: 17592116
[TBL] [Abstract][Full Text] [Related]
8. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: effect of beta-arrestin on internalization kinetics.
Vrecl M; Anderson L; Hanyaloglu A; McGregor AM; Groarke AD; Milligan G; Taylor PL; Eidne KA
Mol Endocrinol; 1998 Dec; 12(12):1818-29. PubMed ID: 9849957
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation.
Charest PG; Bouvier M
J Biol Chem; 2003 Oct; 278(42):41541-51. PubMed ID: 12900404
[TBL] [Abstract][Full Text] [Related]
11. β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor.
Daly C; Guseinov AA; Hahn H; Wright A; Tikhonova IG; Thomsen ARB; Plouffe B
Elife; 2023 Oct; 12():. PubMed ID: 37855711
[TBL] [Abstract][Full Text] [Related]
12. Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.
Bernier V; Lagacé M; Lonergan M; Arthus MF; Bichet DG; Bouvier M
Mol Endocrinol; 2004 Aug; 18(8):2074-84. PubMed ID: 15166253
[TBL] [Abstract][Full Text] [Related]
13. Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction.
Izumi Y; Nakayama Y; Memetimin H; Inoue T; Kohda Y; Nonoguchi H; Tomita K
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1170-6. PubMed ID: 18701631
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization.
Pfeiffer M; Kirscht S; Stumm R; Koch T; Wu D; Laugsch M; Schröder H; Höllt V; Schulz S
J Biol Chem; 2003 Dec; 278(51):51630-7. PubMed ID: 14532289
[TBL] [Abstract][Full Text] [Related]
15. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2005 Apr; 280(15):15315-24. PubMed ID: 15699045
[TBL] [Abstract][Full Text] [Related]
16. Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation.
Oligny-Longpré G; Corbani M; Zhou J; Hogue M; Guillon G; Bouvier M
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):E1028-37. PubMed ID: 22493236
[TBL] [Abstract][Full Text] [Related]
17. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus.
Barak LS; Oakley RH; Laporte SA; Caron MG
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):93-8. PubMed ID: 11134505
[TBL] [Abstract][Full Text] [Related]
18. V
Perkovska S; Méjean C; Ayoub MA; Li J; Hemery F; Corbani M; Laguette N; Ventura MA; Orcel H; Durroux T; Mouillac B; Mendre C
Traffic; 2018 Jan; 19(1):58-82. PubMed ID: 29044966
[TBL] [Abstract][Full Text] [Related]
19. Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation.
Kumari P; Srivastava A; Ghosh E; Ranjan R; Dogra S; Yadav PN; Shukla AK
Mol Biol Cell; 2017 Apr; 28(8):1003-1010. PubMed ID: 28228552
[TBL] [Abstract][Full Text] [Related]
20. Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation.
Memetimin H; Izumi Y; Nakayama Y; Kohda Y; Inoue H; Nonoguchi H; Tomita K
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F620-8. PubMed ID: 19587140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
